Nanjing Pharmaceutical Group Company Limited (SHA:600713)

China flag China · Delayed Price · Currency is CNY
5.44
+0.01 (0.18%)
Apr 29, 2026, 3:00 PM CST
8.80%
Market Cap 7.12B
Revenue (ttm) 54.96B
Net Income (ttm) 624.83M
Shares Out 1.31B
EPS (ttm) 0.43
PE Ratio 12.77
Forward PE n/a
Dividend 0.17 (3.13%)
Ex-Dividend Date Jun 30, 2025
Volume 18,527,540
Average Volume 59,124,985
Open 5.41
Previous Close 5.43
Day's Range 5.37 - 5.46
52-Week Range 4.81 - 6.65
Beta 0.37
RSI 44.59
Earnings Date Apr 11, 2026

About SHA:600713

Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China. [Read more]

Sector Healthcare
Founded 1951
Employees 4,830
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600713
Full Company Profile

Financial Performance

In 2025, SHA:600713's revenue was 54.96 billion, an increase of 2.36% compared to the previous year's 53.70 billion. Earnings were 624.83 million, an increase of 9.50%.

Financial Statements

News

There is no news available yet.